Related Experiment Video
Updated: Jul 26, 2025

06:01
A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
9.6K
Mouse models in colon cancer, inferences, and implications
1Department of Genetics, Harvard Medical School, Boston, MA, USA.
Iscience
|June 19, 2023
Summary
Mouse models are vital for colorectal cancer (CRC) research, aiding drug testing and understanding disease progression. Future studies require immunocompetent, autochthonous models to better reflect the tumor microenvironment and advance immunotherapy.
Area of Science:
- Oncology
- Genetics
- Immunology
Background:
- Mouse models are essential tools in colorectal cancer (CRC) research, facilitating gene discovery and anti-cancer drug development.
- The tumor microenvironment, including angiogenesis and immune components, significantly influences CRC progression and treatment efficacy.
- Recent advancements highlight the need to understand these microenvironments for effective late-stage disease management.
Purpose of the Study:
- To critically evaluate existing mouse models for colorectal cancer (CRC).
- To discuss the strengths and weaknesses of various CRC mouse model constructions.
- To predict the future utility of these models in CRC research, particularly for immunotherapy.
Main Methods:
- Review and synthesis of existing literature on CRC mouse models.
- Analysis of model construction, highlighting inherent advantages and limitations.
- Critical evaluation of model applicability for studying tumor microenvironments and metastatic processes.
Main Results:
- Identified key mouse models crucial for understanding CRC pathology and drug testing.
- Discussed the relevance of tumor, angiogenic, and immune microenvironments in CRC.
- Highlighted the limitations of current models in fully recapitulating human CRC complexity.
Conclusions:
- Genetically engineered mouse models are indispensable for advancing colorectal cancer (CRC) research.
- There is a clear need for immunocompetent and autochthonous mouse models to study the complex tumor microenvironment.
- Such advanced models are critical for the development of novel immunotherapies and checkpoint inhibitors in CRC treatment.

